Genflow Biosciences plc (LON:GENF) will be present at BIO San Diego, which takes place from June 22 to June 25.
The London-listed biotechnology company, will attend the industry event in San Diego as part of its engagement with the wider life sciences and biotechnology community.
Genflow Bio chairman Gad Berdugo will also participate in an mRNA panel during the event. The panel is scheduled for Tuesday, June 23, from 7:30am to 9:00am Pacific Time, at Garibaldi, 901 Bayfront Ct Ste 1, San Diego, CA 92101.
The session is connected with the Alliance for mRNA Medicines, which brings together researchers and industry leaders working to advance mRNA research and support the development of new medicines for patients with serious diseases and unmet medical needs.
Genflow’s presence at BIO San Diego and Berdugo’s participation in the mRNA panel will place the company in discussions linked to biotechnology, therapeutic innovation and the development of new approaches in medicine.
